Stocks > > NEWS
Institutional Investors Open Dialogue with BUGS
CARLSBAD, Calif.--(BUSINESS WIRE)--Dec. 20, 2005--
Robert Brehm, CEO of U.S. Microbics, Inc. (OTCBB: BUGS) (BCN:615212), an innovative environmental products and services company, announced that BUGS has opened discussions with several institutional investors interested in learning more about BUGS and its operating subsidiaries, recent record-breaking revenue increases and investment opportunities for future growth in the environmental services and agricultural growth enhancement products in the international market. The company is seeking up to $20MM for project specific financing and general working capital.
Brehm commented, " Our search for growth capital stems from our significantly better quarterly financial results this year after many years of research and development demonstrating the environmental cleanup technology, seeking a receptive market and developing the political and financial connections necessary for its successful implementation. These new developments include the grant of an innovative patent for carbon reactivation used in air and water filtration products, approval for the use of the patented 'in situ', or below ground, and 'ex-situ', or above ground, technology in Mexico by SEMARNAT (Mexico EPA) for remediation of their contaminated soil and groundwater and successful international clean-up projects in a political venue with proactive political support for environmental programs."
Brehm added, " I believe the world is destined to use our nano-biotechnology, which safely amplifies the forces of Mother Nature, to clean up messes and feed the masses in the 21st century, and now is the time to kick our growth into high gear with a significant financial partner who understands how we can profitably deploy our technology and services to help world leaders attract new investment into their environmentally compliant states and countries and create new jobs and opportunities for their citizens who face daily environmental problems, dirty water resources and food shortages."
Brehm concluded by saying, " I am very encouraged by the interest and excellent response we are getting from the institutional investment community. We are carefully going through the due diligence process to ensure we match up with a strategic financial partner which can provide value beyond the capital as we both help the people of the world solve pressing environmental problems of the 21st century."
About U.S. Microbics, Inc.
U.S. Microbics is a business development and holding company that acquires, develops and deploys innovative environmental technologies for soil, groundwater and carbon remediation, air pollution reduction, modular drinking water systems, and agriculture enhancement. For more information on the company, contact Robert Brehm at 760-918-1860 ext. 102 or visit the website at www.bugsatwork.com. There is also information for the environmental newbie and kids at www.MikeyMicrobe.com.
The information contained in this press release includes forward-looking statements. Forward-looking statements usually contain the words " estimate," " anticipate," " believe," " expect," or similar expressions that involve risks and uncertainties. These risks and uncertainties include the Company's status as a startup company with uncertain profitability, need for significant capital, uncertainty concerning market acceptance of its products, competition, limited service and manufacturing facilities, dependence on technological developments and protection of its intellectual property. The Company's actual results could differ materially from those discussed herein. Factors that could cause or contribute to such differences are discussed more fully in the " Risk Factors," " Management's Discussion and Analysis or Plan of Operation" and other sections of the Company's Form 10-KSB and other publicly available information regarding the Company on file with the Securities and Exchange Commission. The Company will provide you with copies of this information upon request.
Source: U.S. Microbics, Inc.